(Benzotriazol-1-yloxy)dipyrrolidinocarbenium hexafluorophosphate
Need Assistance?
  • US & Canada:
    +
  • UK: +

(Benzotriazol-1-yloxy)dipyrrolidinocarbenium hexafluorophosphate

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Category
Peptide Synthesis Reagents
Catalog number
BAT-006417
CAS number
105379-24-6
Molecular Formula
C15H20N5O?PF6
Molecular Weight
431.32
(Benzotriazol-1-yloxy)dipyrrolidinocarbenium hexafluorophosphate
IUPAC Name
1-[pyrrolidin-1-ium-1-ylidene(pyrrolidin-1-yl)methoxy]benzotriazole;hexafluorophosphate
Synonyms
HBPYU; (BENZOTRIAZOL-1-YLOXY)DIPYRROLIDINOCARBENIUM HEXAFLUOROPHOSPHATE; O-(BENZOTRIAZOL-1-YL)-N,N,N',N'-BIS(TETRAMETHYLENE)URONIUM HEXAFLUOROPHOSPHATE; O-(Benzotriazol-1-yl)-N,N,N',N'-bis(tetramethylene; O-(Benzotriazol-1-yl)-N,N,N',N'-bis(tetramethylene)uronium hexafluorophosphate; (1H-Benzo[d][1,2,3]triazol-1-yl)(di(pyrrolidin-1-yl)methylene)oxonium hexafluorophosphate
Appearance
White to Off-white Podwer
Purity
98% (HPLC)
Melting Point
176 °C (dec.)
Storage
2-8 °C
Solubility
Soluble in Acetonitrile (0.10 g/mL, clear)
InChI
InChI=1S/C15H20N5O.F6P/c1-2-8-14-13(7-1)16-17-20(14)21-15(18-9-3-4-10-18)19-11-5-6-12-19;1-7(2,3,4,5)6/h1-2,7-8H,3-6,9-12H2;/q+1;-1
InChI Key
XKTRAGMCMJYRRN-UHFFFAOYSA-N
Canonical SMILES
C1CCN(C1)C(=[N+]2CCCC2)ON3C4=CC=CC=C4N=N3.F[P-](F)(F)(F)(F)F
1. Facile functionalization at the C4 position of pyrimidine nucleosides via amide group activation with (benzotriazol-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate (BOP) and biological evaluations of the products
Hari K Akula, Hariprasad Kokatla, Graciela Andrei, Robert Snoeck, Dominique Schols, Jan Balzarini, Lijia Yang, Mahesh K Lakshman Org Biomol Chem. 2017 Feb 1;15(5):1130-1139. doi: 10.1039/c6ob02334g.
Reactions of O-t-butyldimethylsilyl-protected thymidine, 2'-deoxyuridine, and 3'-azidothymidine (AZT) with (benzotriazol-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate (BOP) leads to activation of the C4 amide carbonyl by formation of putative O4-(benzotriazol-1-yl) derivatives. Subsequent substitution with alkyl and aryl amines, thiols, and alcohols leads to facile functionalization at this position. Reactions with amines and thiols were conducted either as a two-step, one-pot transformation, or as a one-step conversion. Reactions with alcohols were conducted as two-step, one-pot transformations. In the course of these investigations, the formation of 1-(4-pyrimidinyl)-1H-benzotriazole-3-oxide derivatives from the pyrimidine nucleosides was identified. However, these too underwent conversion to the desired products. Products obtained from AZT were converted to the 3'-amino derivatives by catalytic reduction. All products were assayed for their abilities to inhibit cancer cell proliferation and for antiviral activities. Many were seen to be active against HIV-1 and HIV-2, and one was active against herpes simplex virus-1 (HSV-1).
2. Correction: Facile functionalization at the C4 position of pyrimidine nucleosides via amide group activation with (benzotriazol-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate (BOP) and biological evaluations of the products
Hari K Akula, Hariprasad Kokatla, Graciela Andrei, Robert Snoeck, Dominique Schols, Jan Balzarini, Lijia Yang, Mahesh K Lakshman Org Biomol Chem. 2017 Feb 1;15(5):1268. doi: 10.1039/c7ob90013a.
Correction for 'Facile functionalization at the C4 position of pyrimidine nucleosides via amide group activation with (benzotriazol-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate (BOP) and biological evaluations of the products' by Hari K. Akula, et al., Org. Biomol. Chem., 2017, DOI: 10.1039/c6ob02334g.
3. Facile Modifications at the C4 Position of Pyrimidine Nucleosides via In Situ Amide Activation with 1H-Benzotriazol-1-yloxy-tris(dimethyl-amino)phosphonium Hexafluorophosphate
Hari K Akula, Mahesh K Lakshman Curr Protoc Nucleic Acid Chem. 2019 Mar;76(1):e73. doi: 10.1002/cpnc.73. Epub 2019 Jan 28.
Two approaches for C4 modifications of silyl-protected thymidine, 2'-deoxyuridine, and 3'-azido-2',3'-dideoxythymidine (AZT) are described. In both, nucleoside amide activation with 1H-benzotriazol-1-yloxy-tris(dimethylamino)phosphonium hexafluorophosphate (BOP) and DBU yields O4 -(benzotriazol-1-yl) derivatives. These in situ-formed intermediates are reacted with various nucleophiles, resulting in C4 modifications. In the two-step, one-pot approach, the O4 -(benzotriazol-1-yl) nucleoside intermediates are initially produced by reactions of the nucleosides with BOP and DBU in THF. This step is fast and typically complete within 30 min. Subsequently, the O4 -(benzotriazol-1-yl) derivatives are reacted with nucleophiles, such as aliphatic and aromatic amines, thiols, and alcohols, under appropriate conditions. Workup, isolation, and purification lead to the desired C4-modified pyrimidine nucleosides in good to excellent yields. In the one-step approach, the nucleosides are reacted with BOP and DBU, in the presence of the nucleophile (only aliphatic and aromatic amines, and thiols have been tested). Where comparisons are possible, the one-step approach is generally superior. © 2019 by John Wiley & Sons, Inc.
Online Inquiry
Verification code
Inquiry Basket